Business · 10/07/2007
FDA Approves Deracoxib Supplement for Pain and Inflammation in Dogs
The FDA is amending its animal drug regulations to reflect the approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health US, Inc. for a 75-milligram deracoxib tablet to control pain and inflammation in dogs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →